Valneva

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA https://ow.ly/WT7I50UfW8n

Valneva is presenting and meeting Investors today at the Jefferies London Healthcare Conference. A replay of the fireside chat with our CEO Thomas Lingelbach is available via the following link: https://lnkd.in/dPtCk7Q5

Last week, we joined policymakers from the European institutions, international organizations such as The World Health Organization and other leaders of the vaccine industry to participate in an event hosted by Vaccines Europe at the European Parliament. Together, we discussed the role of immunization in revitalizing Europe’s public health leadership and resilience. Set against the backdrop of the newly elected European Parliament and the start of the 2024-2029 legislative mandate, the event was a crucial moment for our Chief Medical Officer, and Vice President of Vaccines Europe, Dr. Juan Carlos Jaramillo, to continue to engage with policymakers, public health stakeholders and other industry leaders to ensure the development of a strong EU immunization strategy that supports global health initiatives. At Valneva, we are committed to collaborating alongside key stakeholders to continue advancing vaccine strategies. Together, we can help create a healthier and more resilient future for Europe and beyond. #globalhealth #publichealth #vaccine #Europe #AdvancingVaccinesForBetterLives 

📢 Valneva hosted an inspiring internal event that addressed the differences between the four generations currently working at our company, their expectations for a healthy work-life balance and their career goals. 🎉 We welcomed German journalist and keynote speaker Ronja Ebeling, who shared some insights and new perspectives, and encouraged open discussions with around 100 Valneva employees. At Valneva, we are committed to fostering an environment that supports both professional development and family life – but this is not always easy and does not mean the same for everyone. We are pleased to have started this conversation. A big thank you to everyone who took part! #AdvancingVaccinesForBetterLives

Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2 https://ow.ly/WKtI50U6fzS

Last week, Valneva took part in an event focused on how the EU can support national industries in addressing global crises and promote a “preparedness union.” It was organized by #ReFocusAustria at the Permanent Representation of Austria to the EU, and representatives from all EU institutions and the healthcare industry attended. Valneva’s first and only approved chikungunya vaccine developed largely at its R&D hub in Austria served as a case study for EU-wide strategies. Speakers highlighted that factors like climate change make the biotech sector crucial for Europe's crisis preparedness. Thank you for contributing, Richard Hatchett, CEO of CEPI (Coalition for Epidemic Preparedness Innovations), Eloise Todd from the Pandemic Action Network, MEP Andreas Schieder, Laurent Muschel (Director General, hashtag #HERA), Irene Norstedt (Director, DG RTD) and Franck Grimaud (Valneva), and for hosting us, Ambassador Franz Wirtenberger. Photo credit: Zahra Reismüller.

Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences https://lnkd.in/dkBhiJXD

Did you know World Health Organization estimates that vaccines prevent 3.5 to 5 million deaths globally, each year? For centuries, vaccines have played an important role in safeguarding populations from many infectious diseases, from smallpox and influenza to more recently growing threats like mosquito-borne diseases. As science advances, vaccines remain a cornerstone of global health, improving the well-being of communities around the world. At Valneva, we remain committed to advancing vaccines for better lives, working to combat infectious diseases – particularly those with significant unmet medical need. This World Immunization Day, let’s reflect on the impact of vaccines throughout history and how we can continue to advance immunization efforts worldwide. #AdvancingVaccinesForBetterLives #WorldImmunizationDay #GlobalHealth #PublicHealth #Vaccines

Join our nine-month 2024 financial results conference call today at 3 pm CET/ 9 am EDT! https://lnkd.in/dCEJnQrA

Valneva Reports Nine-Month 2024 Financial Results and Provides Corporate Updates https://lnkd.in/e-x5jrjb